| Date Filed | Type | Description |
| 10/12/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/11/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 08/07/2023 |
4
| McDermott Wendy (VP, Human Resources) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 6,000 shares
@ $1.84, valued at
$11k
|
|
| 07/31/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 07/31/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 06/29/2023 |
4
| COATS LONNEL (CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 10,000 shares
@ $2.16, valued at
$21.6k
|
|
| 06/05/2023 |
4
| Artal International S.C.A. (10% Owner) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Bought 27,775,050 shares
@ $2.6, valued at
$72.2M
|
|
| 04/28/2023 |
4
| Swain Judith L (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/28/2023 |
4
| NIES ALAN S (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| LEFKOWITZ ROBERT J MD (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| DEBBANE RAYMOND (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| BARKER SAM L (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 04/28/2023 |
4
| Amouyal Philippe (Director) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Granted 8,032 restricted stock units
@ $0
Granted 12,658 options to buy
@ $2.36, valued at
$29.9k
|
|
| 03/01/2023 |
4
| Alexander Kristen (VP, Finance and Accounting) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 5,330 shares
@ $2.17, valued at
$11.6k
Exercised 5,400 restricted stock units
@ $0
Exercised 2,700 restricted stock units
@ $0
Exercised 10,617 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| Seth Kiernan (VP, Chief Commercial Officer) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 11,813 shares
@ $2.17, valued at
$25.6k
Exercised 14,833 restricted stock units
@ $0
Exercised 5,286 restricted stock units
@ $0
Exercised 22,963 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| McDermott Wendy (VP, Human Resources) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 6,465 shares
@ $2.17, valued at
$14k
Exercised 18,943 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| MAIN ALAN J (EVP, Innov & Chem Sciences) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 20,946 shares
@ $2.17, valued at
$45.5k
Exercised 23,300 restricted stock units
@ $0
Exercised 8,976 restricted stock units
@ $0
Exercised 25,667 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| Kassler-Taub Kenneth B. (SVP, Regulatory & QA) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 19,118 shares
@ $2.17, valued at
$41.5k
Exercised 18,243 restricted stock units
@ $0
Exercised 7,086 restricted stock units
@ $0
Exercised 27,557 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| Granowitz Craig B (SVP, Chief Medical Officer) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 12,732 shares
@ $2.17, valued at
$27.6k
Exercised 27,917 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| Crum Brian T (SVP, General Counsel & Secr.) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 20,537 shares
@ $2.17, valued at
$44.6k
Exercised 21,030 restricted stock units
@ $0
Exercised 8,750 restricted stock units
@ $0
Exercised 26,097 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| WADE JEFFREY L (President and CFO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 30,255 shares
@ $2.17, valued at
$65.7k
Exercised 30,467 restricted stock units
@ $0
Exercised 11,176 restricted stock units
@ $0
Exercised 37,273 restricted stock units
@ $0 |
|
| 03/01/2023 |
4
| COATS LONNEL (CEO) has filed a Form 4 on LEXICON PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 50,971 shares
@ $2.17, valued at
$110.6k
Exercised 84,630 restricted stock units
@ $0
Exercised 33,334 restricted stock units
@ $0
Exercised 91,363 restricted stock units
@ $0 |
|
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
|